I know exactly what I am saying. Did you calculate potential revenues from, diagnostics, imaging and therapuetics? Did you consider that recaf could be used to screen for multiple cancers? Do you realize what the size of the cancer market truly is? Did you also factor in that Biocurex won't have to spend money of their own to develop these products? Remember, in my interview Dr. Moro said he wants to keep therapuetics in house. I imagine their would be a huge demand for an effective product using the recaf technology for therapy. Since virtually every type of cancer has the recaf receptor located on the malignant cell, it is conceivable that ALL of the cancer cells could be destroyed doing very little damage to the normal cells. Look at how inefficient radiation treatment is comparatively, killing a huge # of normal cells, while killing only a few cancerous ones. How big do you think that market is? Granted, it might take ten years from now to develope, but remember, we are talking best case scenario!
So, if you don't think under these kind of circumstances, the company can't fetch a measley $14 billion market cap, I would be astonished!!!
News 
Market Data 
Discover 
